Clinical trial · Observational
Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients
Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Hamartoma Tumor Syndrome (PHTS)
NCT05671107CI-TRIAL-00080868completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to develop a survey completed by parents, caregivers, or other informants that evaluates several important domains of functioning relevant to individuals with neurodevelopmental disorders, including autism spectrum disorder and people with genetic syndromes. Participation in this research will include assisting the research team in the development of the survey measures.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| PTEN Hamartoma Tumor Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| NET | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- PTEN - with NDD
- description
- Patients diagnosed with PTEN Hamartoma Tumor Syndrome and a neurodevelopmental disorder including but not limited to autism spectrum disorder, attention-deficit disorder / attention-deficit hyperactivity disorder, speech language disorder(s), intellectual disability, global developmental delay, oppositional defiant disorder, and / or motor or developmental disorders.
- interventionNames
- Diagnostic Test: NET
- label
- PTEN - without NDD
- description
- Patients diagnosed with PTEN Hamartoma Tumor Syndrome
- interventionNames
- Diagnostic Test: NET
- label
- Sibling Controls
- description
- Siblings related to patients with diagnosis of PTEN Hamartoma Tumor Syndrome
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 3 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Has a PTEN Hamartoma Tumor Syndrome diagnosis with or without a neurodevelopment disorder * Access to a tablet (10+ inch screen), laptop, or desktop computer * Access to reliable internet * Able to attend to short videos (30 plus seconds) * Able to hear audio from a computer device * Able to see without corrective lenses
References
Publications (0)
Data not yet available
No reference posted for this study.